AQR Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $171M | Sell |
|
|||||
|
2025
Q1 | $187M | Buy |
|
|||||
|
2024
Q4 | $81.9M | Buy |
|
|||||
|
2024
Q3 | $9.62M | Buy |
|
|||||
|
2024
Q2 | $5.46M | Buy |
|
|||||
|
2024
Q1 | $1.37M | Sell |
|
|||||
|
2023
Q4 | $9.61M | Sell |
|
|||||
|
2023
Q3 | $78.8M | Sell |
|
|||||
|
2023
Q2 | $95.7M | Sell |
|
|||||
|
2023
Q1 | $117M | Buy |
|
|||||
|
2022
Q4 | $54.4M | Sell |
|
|||||
|
2022
Q3 | $65.8M | Sell |
|
|||||
|
2022
Q2 | $103M | Buy |
|
|||||
|
2022
Q1 | $83.5M | Buy |
|
|||||
|
2021
Q4 | $78.7M | Sell |
|
|||||
|
2021
Q3 | $99.3M | Sell |
|
|||||
|
2021
Q2 | $178M | Sell |
|
|||||
|
2021
Q1 | $284M | Buy |
|
|||||
|
2020
Q4 | $245M | Sell |
|
|||||
|
2020
Q3 | $628M | Sell |
|
|||||
|
2020
Q2 | $583M | Buy |
|
|||||
|
2020
Q1 | $661M | Sell |
|
|||||
|
2019
Q4 | $781M | Sell |
|
|||||
|
2019
Q3 | $815M | Sell |
|
|||||
|
2019
Q2 | $887M | Sell |
|
|||||
|
2019
Q1 | $992M | Buy |
|
|||||
|
2018
Q4 | $950M | Buy |
|
|||||
|
2018
Q3 | $1.07B | Buy |
|
|||||
|
2018
Q2 | $824M | Buy |
|
|||||
|
2018
Q1 | $669M | Buy |
|
|||||
|
2017
Q4 | $626M | Buy |
|
|||||
|
2017
Q3 | $585M | Buy |
|
|||||
|
2017
Q2 | $354M | Buy |
|
|||||
|
2017
Q1 | $285M | Buy |
|
|||||
|
2016
Q4 | $191M | Sell |
|
|||||
|
2016
Q3 | $226M | Buy |
|
|||||
|
2016
Q2 | $83.4M | Buy |
|
|||||
|
2016
Q1 | $74.9M | Sell |
|
|||||
|
2015
Q4 | $249M | Sell |
|
|||||
|
2015
Q3 | $286M | Sell |
|
|||||
|
2015
Q2 | $403M | Buy |
|
|||||
|
2015
Q1 | $352M | Sell |
|
|||||
|
2014
Q4 | $408M | Buy |
|
|||||
|
2014
Q3 | $367M | Buy |
|
|||||
|
2014
Q2 | $250M | Buy |
|
|||||
|
2014
Q1 | $222M | Buy |
|
|||||
|
2013
Q4 | $167M | Buy |
|
|||||
|
2013
Q3 | $92.4M | Sell |
|
|||||
|
2013
Q2 | $91.8M | Buy |
|